Clinical Drug Experience Knowledgebase

avapritinib (Ayvakit)

avelumab (bavencio)

b7-h3 car-t

bortezomib (velcade)

cyclosporine (sandimmune)

durvalumab (imfinzi)

epothilone

fhbg

Filgrastim (neupogen)

fosbretabulin

g207

gallium citrate ga 67

inactivated influenza vaccine

lenvatinib (lenvima)

midazolam (versed)

montanide isa 720

onc206

pentetic acid

prexasertib

ribociclib (kisqali)

ro5126766

rrx-001

scri-carb7h3

sirolimus (rapamune)

sonidegib (odomzo)

tc99m-tilmanocept (Lymphoseek)

trametinib (mekinist)

trebananib

vinblastine (velban)

vorinostat (zolinza)

Blaze Bioscience Inc.

Canadian Cancer Trials Group

Cancer Research Campaign

Case Western Reserve University

Centre Leon Berard

Children's Cancer and Leukaemia Group

Children's National Medical Center

Colorado Health Foundation

Cooperative Trials Group for Neuro-Oncology

Eastern Cooperative Oncology Group

Erasmus University Rotterdam

European Organisation for Research and Treatment of Cancer

Florida International University

Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany

Humboldt University

Icahn School of Medicine at Mount Sinai

Katholieke Universiteit Leuven

Maastricht University

Mayo Clinic

McGill University

Medical Research Council

Merck

National Cancer Institute (NCI)

New York University

North Central Cancer Treatment Group

NRG Oncology

Ostra Sjukhuset

Pfizer

Radiation Therapy Oncology Group

Societe Internationale d'Oncologie Pediatrique (SIOP)

Southwest Oncology Group

St. Jude Children's Hospital

Sugen

The Christie NHS Foundation Trust

The Pacific Pediatric Neuro-Oncology Consortium

The University of Texas, Dallas

Trans Tasman Radiation Oncology Group

University of Birmingham

University of Bologna

University of California, San Francisco

University of Cambridge

University of Duesseldorf

University of Heidelberg

University of Lausanne

University of Leicester

University of Lille

University of Liverpool

University of London

University of Nottingham

University of Rochester

University of Southern California

University of Texas at Houston

University of Toronto

University of Virginia

University of Western Australia

University of Western Ontario

University of Wisconsin

Wake Forest University

Wayne State University

Agenus Inc.

Agouron

Atlantic Health System

Avid Bioservices

Bayer

Baylor University

BeiGene

Bristol-Myers Squibb

British Columbia Cancer Agency

Burzynski Research Institute

Caladrius Biosciences

Celgene

Cephalon

City of Hope National Medical Center

Cornell University

Cortice Biosciences, Inc.

CTI BioPharma

Curie Institute

Dartmouth University

Direct Therapeutics

Duke University

Eisai

Emory University

German Cancer Research Center

Harvard University

Herbert Irving Comprehensive Cancer Center

Hoag Memorial Hospital Presbyterian

Hopital Sainte Justine

immatics Biotechnologies GmbH

Institut Gustave Roussy

Italian Association for Pediatric Hematology Oncology

Johns Hopkins University

Korea Research Institute of Bioscience & Biotechnology

Ligue contre le cancer, France

Loxo Oncology

Medical College of Wisconsin

Michigan State University

Millennium Pharmaceuticals

Millennix

Moorgreen Hospital, Southampton

National Cancer Institute, France

National Institutes of Health (NIH)

National Natural Science Foundation of China

Neurocrine Biosciences

Newcastle University

Northwestern University

Novartis

Oakland University

OHSU Knight Cancer Institute

Oncovir, Inc.

Oregon Health and Science University

Osaka Medical College

Pediatric Brain Tumor Consortium

Pennsylvania State University

Regeneron

Roche

Rongjie Tao

Royal Liverpool & Broadgreen University Hospitals NHS Truts

Royal Marsden Hospital NHS Trust

San Diego Pacific Oncology & Hematology Associates

Schering-Plough

Shandong University

Stanford University

St. Louis University

Tel Aviv University

Temple University

The Pew Charitable Trusts

Thomas Jefferson University

Translational Research Informatics Center, Kobe, Hyogo, Japan

Turning Point Therapeutics

UNICANCER

University of Alabama, Birmingham

University of Arizona

University of Arkansas

University of Brescia

University of Bristol

University of Calgary

University of California, Davis

University of California, Los Angeles

University of California, San Diego

University of Cincinnati

University of Florida

University of Geneva

University of Glasgow

University of Kentucky

University of Leeds

University of Melbourne

University of Michigan

University of Milan

University of Minnesota

University of Montreal

University of Ottawa

University of Padova

University of Paris

University of Pennsylvania

University of Pittsburgh

University of South Florida

University of Texas, San Antonio

University of Ulsan

Vanderbilt University

Vita-Salute University of Milano. Italy

Washington University in St. Louis

Astex Pharmaceuticals, Inc.

Cancer Immunotherapy Trials Network

Cancer Research UK

Cavion LLC

Daiichi Sankyo

EnGeneIC Limited

EpicentRx, Inc.

Ignyta, Inc.

Indiana University

Institut de Cancerologie de l'Ouest Paul Papin

Kazia Therapeutics Limited

Oncoceutics, Inc.

Pacira Pharmaceuticals

Pharmacyclics

PTC Therapeutics

Rush University

State University of New York, Buffalo

Sydney Children's Hospitals Network

SynerGene Therapeutics, Inc.

Tata Memorial Hospital

Tufts University

University of Colorado, Denver

University of Duisburg-Essen

University of Manchester

University of Mannheim

University of Miami

University of New Mexico

University of New South Wales

University of North Carolina at Chapel Hill

University of Vermont

University of Washington

V Foundation

Vion Pharmaceuticals

West Virginia University

Wyeth

Xenova Biomedix